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a  b  s  t  r  a  c  t
Toxoplasmosis  is  a world wide  spread  zoonosis  caused  by  Toxoplasma  gondii,  an  obligate
intracellular  parasite  that is able  to  disseminate  into  deep  tissues  and  cross  biological
barriers,  reaching  immunoprivileged  sites  such  as the  brain  and  retina.  The  parasite  is
able to infect  macrophages  and  dendritic  cells  for  dispersal  throughout  the  body.  How-
ever,  the molecular  mechanisms  or outcomes  of the  subversion  of the  host cell are  largely
unknown.  Recently  our  group  established  that  metalloproteinases  are  involved  in migration
of infected  macrophages.  Herein,  we  evaluated  the  recruitment  of host  invasive  machinery
components  in  T.  gondii  infected  murine  macrophages.  We  showed  by immunoprecipita-
tion  assays  that  MMP-9,  CD44  TIMP-1  and  uPAR  were  secreted  as  a multi-protein  complex
by infected  macrophages.  Zymographic  analysis  revealed  that  MMP-9  was  present  in  its
pro- and  active  form.  Moreover,  inhibition  of uPA/uPAR  pathway  by  PAI-1  decreased  secre-
tion of MMP-9  active  forms,  as well  those  associated  to  uPAR  and  TIMP-1,  but not to  CD44.
Data  presented  here  suggest  that MMP-9  is  secreted  as  a multiprotein  complex  by T.  gondii
infected  macrophages,  similar  to  that  observed  in  metastatic  cells.  We  further  speculate  that
uPA/uPAR system  is  involved  in the  expression/secretion  of  complexes  containing  active
MMP-9  forms.
© 2011 Elsevier B.V. Open access under the Elsevier OA license.. IntroductionToxoplasma gondii is an obligate intracellular parasite
hat infects nucleated cells from warm blooded animals,
resenting a complex life cycle with sexual and asex-
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Open access under the Elsevier OA license.ual phases of development (Dubey and Beattie, 1989).
Tissue cysts or oocysts of this parasite are ingested by
the  deﬁnitive (felines) or accidental host (humans), viable
bradyzoites or sporozoites are released and invade epithe-
lial  cells residing inside parasitophorous vacuoles. T. gondii
induces  a sustained parasite-cellular response and sev-
eral  evading mechanisms guarantee that a non sterilizing
immunity is developed. Therefore asymptomatic individu-
als  carrying live parasites in immunoprivileged sites such
as  the brain and the retina are often identiﬁed (Gazzinelli
et al., 1993; Hunter and Remington, 1994). Several
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studies demonstrated that T. gondii is able to infect murine
leukocytes, using them as “Trojan horses” to cross several
barriers (intestinal and blood–brain) therefore disseminat-
ing throughout the host into deep tissues (Da Gama et al.,
2004; Courret et al., 2006; Lambert et al., 2006).
A number of secreted or transmembrane metallopro-
teinases are involved in cellular migration, degradation of
extracellular matrix components, cross activation of pro-
MMPs  and/or processing of several cell surface-associated
molecules including integrins and CD44 (Itoh and Seiki,
2004; Stefanidakis and Koivunen, 2006). CD44 is a hyaluro-
nan and osteopontin receptor, and actin polymerization
modulates its surface expression and availability for MMP-
9 docking, as described in several metastatic tumors
(Samanna et al., 2007; Redondo-Mun˜oz et al., 2008).
The cleavage of CD44s ectodomain initiates extracellular
matrix components degradation through MMP-9 (Kajita
et al., 2001). These molecules form complexes at the cell
surface in raft domains (Nagano et al., 2004; Cayrol et al.,
2008), and in cancer cells they are up-regulated and form
an invasive machinery, also known as migratory molecular
complex. One of the main components of this complex is
MMP-9, and elevated levels of this molecule are related to
poorer prognosis of several types of metastatic cancer (Shi
et al., 2010; Strongin, 2010). The balance between MMP-9
and TIMP-1 (its endogenous inhibitor) availability is crit-
ical in cerebral malaria (Van den Steen et al., 2006) and
bacterial meningitis (Sulik and Chyczewski, 2008), both
diseases involving blood–brain barrier leakage. Therefore
we hypothesized that these molecules might be involved
in the mechanism by which T. gondii subvert host cells
favoring its dispersal to immuneprivileged sites.
Pericellular proteolysis is initiated by plasminogen
activator plasmin (also known as uPA/uPAR pathway),
composed by the serine urokinase-type plasminogen acti-
vator (uPA) its receptor uPAR and its endogenous inhibitor
PAI-1. Cell invasion and metastasis are also associated
with increased expression of uPAR (Khathib et al., 2001;
Kobayashi et al., 2002; Gutova et al., 2007). In this regard,
in this work we investigate the molecular association of
host’s migratory complex components in T. gondii infected
macrophages. We  demonstrate that T. gondii infection pro-
motes shedding of a multi-protein complex, containing
MMP-9, CD44, TIMP-1 and uPAR. In addition, inhibition of
uPA/uPAR activation by PAI-1 resulted in drastic decrease
of secretion of complexes’ containing MMP-9 active forms.
2. Material and methods
2.1. Animals
Swiss mice were bred and maintained at UENF’s Cen-
tral Animal Facility. T. gondii,  RH strain, was maintained
via intra peritoneal injection in mice. The experimental
protocol was approved by UENF’s Animal Experimentation
Ethics Committee (#16/2006).2.2. Cells
Murine macrophage cell lineage Raw 264.7 was  grown
in 75 cm2 ﬂasks containing DMEM supplemented withsitology 186 (2012) 207– 215
10% FCS, and 0.5% penicillin-streptomycin. Bone mar-
row derived macrophages (BMDM) were generated as
described (Naik et al., 2007) and 95% of cells were F4/80+.
Following infection, cells were cultivated in polypropylene
tubes at 37 ◦C and 5% CO2 atmosphere in DMEM-F12-
supplemented media with 5% FCS. Conditioned media was
collected, centrifuged at 16,000 × g and supernatant was
recovered and used for immunoprecipitation and Western-
blotting analysis performed.
2.3. Inhibitors
In some experiments inhibitors of ERK 1/2 phosphory-
lation, u0126 (Calbiochem), MMP  inhibitor 1 (Calbiochem)
or Plasminogen Activator Inhibitor-1 (PAI-1) [Calbiochem –
human, recombinant mutated at K154T; Q319L; M354I and
N150H (Berkenpas et al., 1995)] were used as follow: 1 M
(after 30 min  of infection), 15 M (after 30 min  of infection)
and 50 nM,  respectively (30 min  prior infection).
2.4. In vitro T. gondii infection
Tachyzoites were adjusted to 5:1 parasites to
macrophage ratio in all experiments. Cell viability was
evaluated by Trypan blue (0.2%) exclusion test 24 h after
infection and it was  above 95%.
2.5. Flow cytometry
Twenty four hours after T. gondii infection, cells were
washed twice with PBS containing 1% BSA and labeled
for 60 min  at 4–8 ◦C in the dark with mAbs against CD44
coupled to biotin (Southern Biotech). Cells were washed
(400 g, 4–8 ◦C, 5 min) with PBS 1% BSA and streptavidin-PE
(eBioscience) for 45 min. After labeling,cells were washed
and ﬁxed with 1% formaldehyde and analyzed by ﬂow
cytometry and 15,000–20,000 events were collected using
a FACScalibur from BD. Results of median intensity ﬂuores-
cence (MFI) from 3 independent experiments are shown.
2.6. Immunoprecipitation and zymography
Immunoprecipitation was  performed on conditioned
medium 24 h after infection of 3 × 107 cells. Protein G
agarose (Calbiochem) was incubated with 2 g of anti-
MMP-9 (C-20), anti-HCAM (N-18), anti-TIMP-1 (R-18) or
anti-uPAR (L-17) [Santa Cruz Biotech] for 18 h at 4 ◦C and
mixed with the resulting supernatants for an additional
3 h incubation. Pellets containing immune complexes were
washed with Low RIPA buffer (20 mM Tris–HCl pH 7.5,
150 mM NaCl2, 2 mM EDTA, 0, 5% Triton X-100). For zymog-
raphy the pellet was suspended in sample buffer without
-mercaptoethanol (-MCE). Host cell metalloproteinases
were subjected to SDS-PAGE using 8% polyacrylamide gels
containing 0.1% gelatin. After electrophoresis, gels were
rinsed with Tris–HCl pH7.5 buffer containing 2.5% Tri-
ton X-100 at 37 ◦C. After 48 h of incubation with Tris–HCl
pH7.5 buffer containing 200 mM NaCl, 10 mM CaCl2 and
2.5% Triton X-100 at 37 ◦C; gels were stained with 0.25%
of Comassie blue and areas of gelatinolytic activity were
visualized as clear bands.
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Fig. 1. Co-immunoprecipitation of MMP-9 and CD44 from culture supernatant of Toxoplasma gondii infected bone marrow derived macrophages. BMDM
were  infected for 24 or 48 h with T. gondii and supernatant of cell cultures were collected, centrifuged and submitted to immunoprecipitation with (A) anti-















ure  presented. * (p < 0.05) and ** (p < 0.01) One-Way Anova.
.7. Densitometric assays
Gels were digitalized using a Canon EOS Rebel XTi
0.1 Megapixels camera, in most pictures colors were
nverted and contrast enhanced and transformed in gray
cale by Corel PhotoImpact X3 software. The relative inten-
ity of the gelatin degradation by imunnoprecipitaded
rotein was quantiﬁed by densitometry, using the com-
utational program “Gel Perfect”, which calculates relative
obility of each band and the occupied area (Densitomet-
ic Units-DU) (Bozzo and Retamal, 1991; Retamal et al.,
999). For some experiments Gel DocTM XR+ (Bio-Rad) was
sed.
.8. Statistical analysisData are presented as mean ± S.D., and unpaired two
ailed t test or One-Way Anova were used for comparisons,
sing the GraphPad Prism software.3. Results
3.1. Active MMP-9 is secreted by T. gondii infected
macrophages coupled to CD44, TIMP and uPAR
It is well known that T. gondii infects a variety of
cells such as macrophages, monocytes and dendritic cells
using them as “Trojan horses” to disseminate throughout
the host. However the molecular mechanism by which T.
gondii subvert these cells into crossing intestinal, blood
and retinal barriers remains to be fully elucidated. In this
regard, our group recently demonstrated that membrane
matrix metalloproteinases (MT1-MMP  and ADAM-10) are
up-regulated and MMP-9 secretion is augmented during
macrophage infection (Seipel et al., 2010). Secretion of
MMP-9 in metastatic cells requires an intermediary step
which involves docking and tethering at cell surface, medi-
ated by CD44 (Redondo-Mun˜oz et al., 2008).
To explore this mechanism, supernatants from
infected or uninfected BMDM were subjected to
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Fig. 2. Co-immunoprecipitation of active MMP-9 and CD44 induced by live parasites. BMDM were infected for 24 h with T. gondii and supernatant of
cell  cultures were collected, centrifuged and submitted to immunoprecipitation with (A) anti-MMP-9, (B) anti-CD44 followed by zymographic analysis.
Densitometric analysis were performed and mean ± SD of the ratio between active and pro-MMP-9 values (n = 2) of one representative experiment are
presented. *** (p < 0.001) One-Way Anova.
immunoprecipitation with anti-MMP-9 or anti-CD44
followed by zymographic assay. Enzimatic analysis of
immunoprecipitates showed that zimogen form of MMP-9
was increased after 24 h and 48 h of infection and that
conversion to active form was further increased after 48 h
of infection (Fig. 1A). Co-imunoprecitipation of CD44 with
MMP-9 in its zimogen and active form was observed after
24 or 48 h of infection (Fig. 1B), suggesting the presence
of CD44 coupled to MMP-9 at the conditioned medium.
The presence of active MMP-9/CD44 cleaved ectodomain
was observed only when parasites were alive (Fig. 2A and
B). Cleavage of CD44 during MMP-9 secretion is ERK1/2
dependent (Takino et al., 2006), therefore, we next investi-
gate if ERK phosphorylation or MMP  dependent processing
blockage were involved in T. gondii induced CD44/MMP-9
secretion. Decreased levels of pro-MMP9 were observed
in supernatants of uninfected u0126 (inhibits MEKK1
blocking ERK1/2 phosphorylation) treated cells with
simultaneous CD44 increase at cell surface (Fig. 3A and B).
Inhibition of MMP  processing by MMP  inhibitor I did not
altered signiﬁcantly cell surface expression or secretion of
MMP-9/CD44 after infection.In order to verify similarities between metastatic
invasion complexes and complexes secreted by T. gondii
infected macrophages containing CD44/MMP-9; we per-
formed immunoprecipitations with anti-MMP-9, anti-
CD44, anti-TIMP-1 or anti-uPAR followed by zymographic
analysis (Figs. 4 and 5). We  evaluate whether the co-
immunoprecipitated MMP-9 was  in its’ active form in those
complexes. CD44, TIMP-1 or uPAR co-immunoprecipitated
MMP-9 active forms in supernatant from infected
macrophages (Fig. 4A and B, Fig. 5A and B), as showed by
zymographic analysis.
3.2. uPA/uPAR system is involved in the secretion of
MMP-9 by T. gondii infected macrophages
We next examine if the MMP-9 secretion by infected
cells was  mediated by the uPA/uPAR pathway. uPA con-
verts plasminogen into plasmin while coupled to uPAR
at cell surface, that cleaves MMPs  zymogens into their
active forms (Khathib et al., 2001). uPA/uPAR are located
at focal adhesion of several tumors and are implicated
in MMP-9 activation (Menshikov et al., 2006) and CD44
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Fig. 3. CD44 cell surface expression in infected macrophages. Raw 264.7 macrophages were infected for 24 h with T. gondii and (A) supernatant of cell
cultures were collected, centrifuged and submitted to immunoprecipitation with anti-CD44 followed by zymogram analysis. Where indicated cells were
i ion. Alte


























Tncubated with u0126 1 M or 15 M MMP  inhibitor I short after infect
ow  cytometry analysis for cell surface expression. Results are represen
ytometric analysis). ** (p < 0.005) and * (p < 0.02) unpaired two  tailed t te
ctodomain cleavage (Takino et al., 2006). Inhibition of
PA/uPAR activation by a recombinant mutant form of
AI-1, its’ endogenous inhibitor, decreased secretion of
ctive forms of MMP-9 (Fig. 4A). However, secretion of
D44/MMP-9 was not signiﬁcantly diminished by PAI-1
Fig. 4B). The decrease in active form of MMP-9 secretion
as more pronounced when cells were starved prior PAI-1
reatment and infection and supernatants immunoprecip-
tated with anti-TIMP-1 or anti-uPAR (Fig. 5A and B).
. Discussion
The establishment of toxoplasmosis infection requires
hat T. gondii sporozoites get released from ingested
ocysts and penetrate into intestinal epithelial cells, where
hey convert to tachyzoites. This parasite form must be able
o cross biological barriers and disseminate to organs either
ematogenously or via lymphatics (Hunter and Remington,
994). The way, in which the parasite resides inside
ermissive leukocytes, reach immunoprivileged sites by
rossing the blood–brain barrier either through a facil-
tated entry mechanism or by direct transmigration, is
eginning to be understood. Several groups have demon-
trated that T. gondii is able to infect murine macrophages,
onocytes and dendritic cells (Da Gama et al., 2004;
ourret et al., 2006; Lambert et al., 2006) and use them
s “Trojan horses” to disseminate throughout the host.
he regulation of the expression of secreted or membranernatively, macrophages were stained with anti-CD44 and submitted to
ean ± SD of 3 independent assays of mean intensity ﬂuorescence (ﬂow
matrix metalloproteinases, integrins and/or other dock-
ing molecules is fundamental during this process. In this
regard, we recently demonstrated that secretory and MT-
MMPs  are up-regulated in T. gondii infected macrophages
(Seipel et al., 2010). Cerebral tuberculosis also shows
increased secretion of MMP-9 by astrocytes (Harris et al.,
2007) and inhibition of MMP  in mice infected with
Mycobacterium tuberculosis decreases the dissemination of
mycobacteria by the hematogenous route (Izzo et al., 2004).
Macrophages from healthy cured individuals with previ-
ous mucosal leishmaniasis show elevated levels of MMP-9
when compared to the localized cutaneous form (Maretti-
Mira et al., 2011), pointing MMP-9 as a contributor in
pathogen dissemination.
The role of MMPs  in T. gondii infection is recently begun
to be unveiled. Mun˜oz and collaborators (Mun˜oz et al.,
2009) showed that MMP-2−/− but not MMP-9−/− mice
presented a signiﬁcant reduction of ileum destruction com-
pared to wild type mice. On the other hand, MMP-8 and
-10, as well TIMP-1 were implicated in the trafﬁcking of T
lymphocytes into CNS of mice infected by intra-peritoneal
route (Clark et al., 2011). Those apparently conﬂicting
results might indicate different roles of MMPs  at distinct
infection phases and/or tissues.The regulatory mechanisms, intracellular signaling,
molecular processing and/or secretion events regarding
MMPs  at T. gondii infection have yet to be fully elucidated.
In this work, co-immunoprecipitation assays followed by
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Fig. 4. Immunoprecipitation and zymographic analysis of MMP-9 associated molecules present at culture supernatants of Toxoplasma gondii infected
macrophages and the inﬂuence of uPA/uPAR system. Raw 264.7 macrophages were treated or not with 50 nM of PAI-1 and were infected for 24 h with T.
gondii  (Tg). Uninfected (control) cells were used as controls. Supernatant of cell cultures were collected, centrifuged and submitted to immunoprecipitation
with  anti-MMP-9 (A) or anti-CD44 (B) followed by zymographic analysis in 8% polyacrylamide gels with 0.1% gelatin for MMP-9 activity. Gels were digitalized
and  densitometry of the gelatin degraded bands was obtained. Results are expressed as densitometric units (DU) of 94/92 KDa pro-MMP-9, or the total of
ferent as
< 0.005)(88,  83 and/or 62 KDa) active peptide (results are representative of 3 dif
(densitometric units of 3 independent experiments). *** (p < 0.001); ** (p zymographic analysis demonstrated that active MMP-9,
CD44 and TIMP-1 were increased in culture supernatants
24 and 48 h after infection; moreover these molecules were
secreted coupled to soluble uPAR. Secretion of MMP-9says). Results are respresented as mean ± SD of pro/active MMP-9 ratio
; and * (p < 0.02) unpaired two tailed t test.requires an intermediary step which involves docking and
tethering at cell surface. uPAR, CD44 and v3 integrins
form a complex at the cell surface where CD44 function as a
docking structure for pro-MMP-9 in cancer metastasis, and
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Fig. 5. Immunoprecipitation and zymographic analysis of MMP-9 associated molecules present at culture supernatants of Toxoplasma gondii infected
macrophages and the inﬂuence of uPA/uPAR system. Cells were starved for 18 h and then treated or not with 50 nM of PAI-1 and infected for 24 h with
T.  gondii.  Uninfected cells were used as controls. Supernatant of cell cultures were collected, centrifuged and submitted to immunoprecipitation with
anti-TIMP-1 (A) or anti-uPAR (B) followed by zymographic analysis in 8% polyacrylamide gels with 0.1% gelatin for MMP-9 activity. Gels were digitalized











l88,  83 and/or 62 KDa) active peptide (results are representative of 3 diff
densitometric units of 3 independent experiments). *** (p < 0.001); ** (p 
hese molecules are often secreted as multi-protein com-
lex (Khathib et al., 2001; Redondo-Mun˜oz et al., 2008). In
his work we demonstrated that MMP-9, TIMP-1, CD44 are
o-immunoprecipitated with uPAR, suggesting that similar
vents might take place during macrophage harboring by
. gondii.Furthermore, we observed that T. gondii infection
ncreased secretion of 88, 83 and 62 KDa MMP-9 active
orms by macrophages corroborating with previously pub-
ished data (Rosenblum et al., 2007; Geurts et al., 2008). Itsays). Results are respresented as mean ± SD of pro/active MMP-9 ratio
; and * (p < 0.02) unpaired two tailed t test.
is possible that the 88 and 83 KDa bands being the most
likely product of the zymogen 94/92 KDa peptide process-
ing (Strongin, 2010; Parmo-Caban˜as et al., 2006), and the
62 KDa peptide due autocatalytic action of MMP-9 (Rosen-
blun et al., 2007).
In addition, we  have demonstrated that active forms
of MMP-9 are co-immunoprecipitated with uPAR, TIMP-
1 and CD44 from the supernatant of infected macrophages,
suggesting similarities between migration behaviors of
T. gondii infected cells and metastatic tumors. The
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uPA/uPAR system of activation, involved in MMP-9 expres-
sion/secretion, is regulated by endogenous plasminogen
activator inhibitors 1 and 2 (PAI-1, PAI-2) and by the
protease nexin 1 (PN-1) (Kanse et al., 2004; Czekay and
Loskutoff, 2009). Addition of PAI-1 previous to infection
drastically reduces secretion of MMP-9 active forms asso-
ciated to uPAR and TIMP-1. Biding of PAI-1 to uPA/uPAR
promotes rapid internalization of PAI/uPA/uPAR com-
plexes and binding of integrins with LDL-receptor-related
protein 1 (Czekay and Loskutoff, 2009). Furthermore there
is direct evidence that inhibition of uPA/uPAR expres-
sion by siRNA inhibits secretion of MMP-9 (Ahmad et al.,
2009). We  have evidence that upon PAI-1 treatment, T.
gondii infected cells increased the amounts of intracellular
MMP-9 (data not shown), however, further investigation
aiming the intracellular route of expression/secretion of
this complex is needed to clarify which mechanisms are
involved in infected cells under PAI-1 pressure. The exper-
iments related here did not show signiﬁcant decreasing in
CD44/MMP-9 in infected macrophages treated with PAI-1.
CD44 are class I transmembrane glycoproteins product of
alternative splicing of variant exons, involved in cell–cell
and cell–matrix interactions, binding to hyaluronan (HA)
and osteopontin (OPN). Moreover, CD44 participates in
many cellular processes, such as, growth, survival, differen-
tiation and motility (Rangaswami et al., 2006). Stimulation
of CD44 by degraded hyaluronic acid (low MW HA) present
at inﬂammatory sites induces up-regulation of uPA and
uPAR expression but not necessarily increases MMP-9
secretion (Kobayashi et al., 2002). Changes in N- and
O-glycosylation are known to modulate CD44 cleavage
(Gasbarri et al., 2003) and preference of splincing vari-
ants associated to uPA/uPAR/PAI-1 pathway have also been
related (Rozeman et al., 2009). Furthermore, T. gondii met-
allo and/or serine proteinases might play an essential role
during macrophage harboring: (1) processing MMP-9 from
zymogen to its active form (2) cleaving CD44 ectodomain
or HA in lower molecular forms. Further studies address-
ing molecular interactions and/or signaling at membrane
lipid raft microdomains in addition to trafﬁcking of this
multi-protein complex through the cell toward secretion
to the extracellular mileu, are imminently needed. Data
from these future experiments will provide fundamental
clues for a better understanding on how T. gondii trig-
ger such controlled machinery and favor its dissemination
through the host, facilitating access of infected leukocytes
to immunoprivileged sites.
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